SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : JNJ-Super company, Super stock!
JNJ 159.53-0.5%Oct 7 9:30 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Sr K6/16/2017 8:35:15 AM
1 Recommendation

Recommended By
Lance Bredvold

   of 552
 
3:51 am Johnson & Johnson completes acquisition of Actelion ( ALIOY) ( JNJ) :

Johnson & Johnson ( JNJ) announced the completion of the acquisition of Actelion ( ALIOY) for a total purchase price of ~$30 bln in cash.

  • Actelion will now become part of the Janssen Pharmaceutical Companies of Johnson & Johnson.
    • In connection with the completion of the public tender offer, Actelion has spun off its drug discovery operations and early-stage clinical development assets into a newly created Swiss biopharmaceutical company, Idorsia
    Report TOU ViolationShare This Post
     Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

    HomeMailHotSubjectMarksPeopleMarksKeepersSettings
    Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
    © 2024 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News